Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial

By Palmieri A.   Imbimbo C.   Creta M.   Verze P.   Fusco F.   Mirone V.  

International Journal of Andrology, Vol. 35, Iss. 2, 2012-04 ,pp. : 190-195

Blackwell Publishing

Access to resources Recommend Favorite

Collagenase clostridium histolyticum: a novel nonsurgical option for the treatment of Peyronie’s disease

By Aliperti Louis A   Trost Landon W   Hellstrom Wayne JG  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 5, 2013-10 ,pp. : 531-540

Future Medicine

Access to resources Recommend Favorite

Vitamin E Use Is Associated with Improved Survival in an Alzheimer’s Disease Cohort

By  

Dementia and Geriatric Cognitive Disorders, Vol. 28, Iss. 6, 2009-12 ,pp. : 536-540

Karger

Access to resources Recommend Favorite

Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases

By Denas G.   Marzot F.   Offelli P.   Stendardo A.   Cucchini U.   Russo R.   Nante G.   Iliceto S.   Pengo Vittorio  

Journal of Thrombosis and Thrombolysis, Vol. 27, Iss. 3, 2009-04 ,pp. : 340-347

Springer Publishing Company

Access to resources Recommend Favorite

Plasma Levels of Antioxidants Are Not Associated with Alzheimer’s Disease or Cognitive Decline

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 2-3, 2005-02 ,pp. : 134-139

Karger

Access to resources Recommend Favorite